A comparison study of metformin only therapy and metformin combined with Chinese medicine jianyutangkang therapy in patients with type 2 diabetes: A randomized placebo-controlled double-blind study

Complementary Therapies in Medicine

Volumn 24, Issue , 2016, Pages 13-18

  Hu, Yuan ^a   Zhou, Xin ^a   Liu, Ping ^a   Wang, Bo ^a   Duan, Dong Mei ^a   Guo, Dai Hong ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

FBG; HbA1c; Integrated traditional Chinese and western medicine; JYTKP; Type 2 diabetes

Indexed keywords

CHINESE DRUG; GLUCOSE; HEMOGLOBIN A1C; JIANYUTANGKANG; LIPID; METFORMIN; PLACEBO; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HERBACEOUS AGENT;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; KINESIOTHERAPY; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; AGED; ANALYSIS; DIABETES MELLITUS, TYPE 2; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DRUGS, CHINESE HERBAL; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED;

EID: 84957673439     PISSN: 09652299     EISSN: 18736963     Source Type: Journal    
DOI: 10.1016/j.ctim.2015.11.005     Document Type: Article

References (35)

1. Shaw J.E., Sicree R.A., Zimmet P.Z. Global estimates of the prevalence of diabetes forand 2030. Diabetes Res Clin Pract 2010, 87:4-14.
2. Wong I.O.L., Cowling B.J., Schooling C.M. Vulnerability to diabetes in Chinese: an age-period-cohort analysis. Ann Epidemiol 2015, 25:34-39.
3. Wang T.J., Larson M.G., Vasan R.S., Cheng S., Rhee E.P., McCabe E., et al. Metabolite profiles and the risk of developing diabetes. Nat Med 2011, 17:448-453.
4. Ohtsubo K., Chen M.Z., Olefsky J.M., Marth J.D. Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport. Nat Med 2011, 17:1067-1075.
5. Bell D.S., Al Badarin F., Jr.O'Keefe J.H. Therapies for diabetic dys-lipidemia. Diabetes Obes Metab 2011, 13:313-325.
6. Sun Z., Miller R.A., Patel R.T., Chen J., Dhir R., Wang H., et al. Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration. Nat Med 2012, 18:934-942.
7. Coccheri S. Approaches to prevention of cardiovascular complications and events in diabetes mellitus. Drugs 2007, 67:997-1026.
8. Stolar M.W. Defining and achieving treatment success in patients with type 2 diabetes mellitus. Mayo Clin Proc 2010, 85.
9. Bian Z.-X., Moher D., Dagenais S., Li Y.-P., Liu L., Wu T.-X., et al. Improving the quality of randomized controlled trials in Chinese herbal medicine, part II: control group design. Zhong xi yi jie he xue bao = J Chin Integr Med 2006, 4:130-136.
10. Wang E., Wylie-Rosett J. Review of selected Chinese herbal medicines in the treatment of type 2 diabetes. Diabetes Educ 2008, 34:645-654.
11. Jayaprakasam B.O.L., Schutzki R.E., Tai M.H., Nair M.G. Amelioration of obesity and glucose intolerance in high-fat-fed C57BL/6 mice by anthocyanins and ursolic acid in Cornelian cherry (Cornus mas). J Agric Food Chem 2006, 54:243-248.
12. Huseini H.F., Hasani-Rnjbar S., Nayebi N., Heshmat R., Sigaroodi F.K., Ahvazi M., et al. Capparis spinosa L. (Caper) fruit extract in treatment of type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. Complement Ther Med 2013, 21:447-452.
13. Kianbakht S., Dabaghian F.H. Improved glycemic control and lipid profile in hyperlipidemic type 2 diabetic patients consuming Salvia officinalis L. leaf extract: a randomized placebo. Controlled clinical trial. Complement Ther Med 2013, 21:441-446.
14. Huyen V.T.T., Phan D.V., Thang P., Hoa N.K., Ostenson C.G. Antidiabetic effect of Gynostemma pentaphyllum tea in randomly assigned type 2 diabetic patients. Horm Metab Res 2010, 42:353-357.
15. Vray M., Attali J.R. Randomized study of glibenclamide versus traditional Chinese treatment in type 2 diabetic patients. Diabetes Metab 1995, 21:433-439.
16. Brown A.S. Use of combination therapy for dyslipidemia: a lipid clinic approach. Am J Cardiol 2002, 90:44-49.
17. Leem K.-H., Lee S., Kim H.K. Extrusion process enhances the anti-inflammatory effect of Acanthopanax senticosus leaves. Food Sci Biotechnol 2014, 23:911-916.
18. Kim K.H., Ha S.K., Choi S.U., Kim S.Y., Lee K.R. Phenolic constituents from the twigs of Euonymus alatus and their cytotoxic and anti-inflammatory activity. Planta Med 2013, 79:361-364.
19. Li X., Cui X., Wang J., Yang J., Sun X., Li X., et al. Rhizome of Anemarrhena asphodeloides counteracts diabetic ophthalmopathy progression in streptozotocin-induced diabetic rats. Phytother Res 2013, 27:1243-1250.
20. Hao A.Z., Chen L.P., Wang F.W., Jin D.S., Duan D.M. Effect of xiaokehuayu pills on blood glucose and lipid in diabetic rats. Chin J Health Care Med 2008, 4:284-286.
21. Wang F.W., Hao A.Z., Chen L.P., Jin D.S., Duan D.M. Effect of xiaokehuayu pills on blood glucose and superoxide dismutase activity of diabetic rats. China J Tradit Chin Med Pharm 2015, 8:1089-1091.
22. Schulz K.F., Altman D.G., Moher D., et al. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010, 23:332-340.
23. Ghadge A.A., Harke S.M., Khadke S.P., Diwan A.G., Pankaj M., Kulkarni O.P., et al. Circulatory adipocytokines and lipid profile variations in type-2 diabetic subjects: desirable side-effects of antidiabetic drugs. Diabetes Metab Syndr 2014, 8:230-232.
24. Xie W., Zhao Y., Zhang Y. Traditional chinese medicines in treatment of patients with type 2 diabetes mellitus. Evid Based Complement Altern Med eCAM 2011, 2011:726723.
25. Chen W., Zhang Y., Liu J.P. Chinese herbal medicine for diabetic peripheral neuropathy. Cochrane Database Syst Rev 2011, CD007796.
26. Zhen Z., Chang B., Li M., Lian F.-M., Chen L., Dong L., et al. Anti-diabetic effects of a Coptis chinensis containing new traditional Chinese medicine formula in type 2 diabetic rats. Am J Chin Med 2011, 39:53-63.
27. Dey L., Attele A.S., Yuan C.S. Alternative therapies for type 2 diabetes. Altern Med Rev J Clin Ther 2002, 7:45-58.
28. Ozcan M.M. Investigation on the mineral contents of capers (Capparis spp.) seed oils growing wild in Turkey. J Med Food 2008, 11:596-599.
29. Triggiani V., Resta F., Guastamacchia E., Sabba C., Licchelli B., Ghiyasaldin S., et al. Role of antioxidants, essential fatty acids, carnitine, vitamins, phytochemicals and trace elements in the treatment of diabetes mellitus and its chronic complications. Endocr Metab Immune Disord Drug Targets 2006, 6:77-93.
30. Prabhakar P.K., Kumar A., Doble M. Combination therapy: a new strategy to manage diabetes and its complications. Phytomedicine 2014, 21:123-130.
31. Kilpatrick E.S. Haemoglobin A(1c) in the diagnosis and monitoring of diabetes mellitus. J Clin Pathol 2008, 61:977-982.
32. Goldenberg R.M., Cheng A.Y.Y., Punthakee Z., Clement M. Use of glycated hemoglobin (A1C) in the diagnosis of type 2 diabetes mellitus in adults. Can J Diabetes 2011, 35:247-249.
33. Yun S.I., Park H.O., Kang J.H. Effect of Lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes. J Appl Microbiol 2009, 107:1681-1686.
34. Murguia-Romero M., Rafael Jimenez-Flores J., Sigrist-Flores S.C., Espinoza-Camacho M.A., Jimenez-Morales M., Pina E., et al. Plasma triglyceride/HDL-cholesterol ratio, insulin resistance, and cardiometabolic risk in young adults. J Lipid Res 2013, 54:2795-2799.
35. Fryer L.G.D., Parbu-Patel A., Carling D. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem 2002, 277:25226-25232.